Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Seattle Genetics, Inc. (SGEN)

« Back to company index

SGEN Chatter Timeline

Stock Ticker for SGEN

Most Active Tweeters for SGEN

UserTweets
@stock_titan 6
@sleekoptions 6
@MarcJacksonLA 4
@FlashAlert_me 4
@newsfilterio 3

Recent Tweets for SGEN

MarcJacksonLA @MarcJacksonLA
$SGEN $ALPMY Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications fo… https://t.co/Kq3tVXJgBL
April 19th 2021, 9:04pm
TradeWithAlerts @TradeWithAlerts
Large Print $SGEN Size: 167784 Price: 144.01 Time: 1600 Amount: $24,162,573.84
April 19th 2021, 8:04pm
equity_newswire @equity_newswire
$SGEN Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications for PADCE… https://t.co/xlEKMVxrdB
April 19th 2021, 6:04pm
Briefingcom @Briefingcom
$SGEN: Seagen and Astellas Pharma announce that FDA files two supplemental Biologics License Applications for PADCEV https://t.co/W2Ywcm9H7C
April 19th 2021, 2:04pm
Mikalche @Mikalche
$SGEN FDA accepts Seagen, Astellas' enfortumab vedotin applications in urothelial cancer https://t.co/3UtuY7SSds
April 19th 2021, 12:04pm
newsfilterio @newsfilterio
FDA accepts Seagen, Astellas' enfortumab vedotin applications in urothelial cancer $SGEN https://t.co/NCD1aAtxf7
April 19th 2021, 12:04pm
Hall8Jack @Hall8Jack
RT @BioStocks: $SGEN and Astellas Announce FDA Acceptance of Two sBLA's for PADCEV in Locally Advanced or Metastatic Urothelial Cancer. $AL…
April 19th 2021, 12:04pm
sbwcws @sbwcws
Seagen, Astellas Pharma: FDA accepts two sBLAs for PADCEV $SGEN $ALPMY
April 19th 2021, 12:04pm
sbwcws @sbwcws
Seagen, Astellas Pharma announce FDA acceptance of Padcev sBLAs for RTOR pilot $SGEN $ALPMY
April 19th 2021, 12:04pm
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed]: Issued Press Release on April 19, 08:00:00: Seagen and Astellas Announce U.S. FDA Acceptance… https://t.co/Xppl7mlJ0i
April 19th 2021, 12:04pm
BioStocks @BioStocks
$SGEN and Astellas Announce FDA Acceptance of Two sBLA's for PADCEV in Locally Advanced or Metastatic Urothelial Ca… https://t.co/dA0W4ZJxAQ
April 19th 2021, 12:04pm
stock_titan @stock_titan
$SGEN Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications for PADCE… https://t.co/cgsPrxdInI
April 19th 2021, 12:04pm
stock_titan @stock_titan
$SGEN $ALPMY Astellas and Seagen Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications fo… https://t.co/7VUzEl0bBC
April 19th 2021, 12:04pm
Amp_Trades @Amp_Trades
$SGEN Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications for PADCE… https://t.co/vx6o3Iee1G
April 19th 2021, 12:04pm
sleekoptions @sleekoptions
Peak profit for the last 6 expired option alerts for $SGEN 137.23% | 269.23% | 341.18% | 117.65% | 104.63% | 156.73… https://t.co/2T8DBCuPAm
April 17th 2021, 2:04pm
sleekoptions @sleekoptions
$SGEN - #OptionsTrading - Monthly performance of the algo based option alerts posted for SGEN https://t.co/pwvJVo4izH
April 17th 2021, 2:04pm
sleekoptions @sleekoptions
$SGEN - Last six months, 21 option alerts peaked above 100% after they were triggered by the algo… https://t.co/PxUoClhwXU
April 17th 2021, 2:04pm
MarcJacksonLA @MarcJacksonLA
$SGEN - Seagen: The New Oncology Hope. https://t.co/QVeAVpCMtF https://t.co/EM8MzSPXK9
April 17th 2021, 12:04am
BentNyegaard @BentNyegaard
RT @EgidiusLambrech: 2021 "inflection point" for #Genmab, says chief executive $GMAB $SGEN #Tisotumab Vedotin https://t.co/ti9EvqKGWY
April 16th 2021, 1:04pm
EgidiusLambrech @EgidiusLambrech
2021 "inflection point" for #Genmab, says chief executive $GMAB $SGEN #Tisotumab Vedotin https://t.co/ti9EvqKGWY
April 16th 2021, 12:04pm
ChartMill @ChartMill
$SGEN has a Profit Margin of 28.21%. This is amongst the best returns in the industry. https://t.co/j2QOtQY97n https://t.co/BYUv8rKvZQ
April 15th 2021, 9:04pm
sleekoptions @sleekoptions
$SGEN Was up 1.12 %. Turned negative -0.55% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/RVcCJW2TeZ
April 14th 2021, 3:04am
Gambiste1 @Gambiste1
RT @savage_swings: $SGEN #Earnings 4/29 Recent earnings beat on 2/11 Chart looks like a recent breakout and a back test. Good entry point,…
April 14th 2021, 1:04am
savage_swings @savage_swings
$SGEN #Earnings 4/29 Recent earnings beat on 2/11 Chart looks like a recent breakout and a back test. Good entry p… https://t.co/RuadZCZox3
April 14th 2021, 1:04am
Michaelrose102 @Michaelrose102
Basically everyone in biotech getting slammed. Here’s an example. In October Merck $mrk made a deal with $sgen and… https://t.co/aOuHCO9K9i
April 13th 2021, 4:04pm
LifeSpecialist4 @LifeSpecialist4
Waiting for biotech stocks to go up again. Would buy more $SGEN and $OCUL if I didn't have a mortgage.
April 13th 2021, 1:04am
TMLTraderr @TMLTraderr
RT @TMLTrader: $SGEN recently broke out of its flat base (168.10 std pivot) on heavy volume.  Pulled back this week just below pivot and ab…
April 12th 2021, 8:04pm
TradeWithAlerts @TradeWithAlerts
Large Print $SGEN Size: 136945 Price: 140.72 Time: 1600 Amount: $19,270,900.40
April 12th 2021, 8:04pm
sleekoptions @sleekoptions
Peak profit for the last 6 expired option alerts for $SGEN 137.23% | 269.23% | 341.18% | 117.65% | 104.63% | 156.73… https://t.co/4RlxKplv2x
April 12th 2021, 2:04pm
sleekoptions @sleekoptions
$SGEN - Last six months, 21 option alerts peaked above 100% after they were triggered by the algo… https://t.co/gPPTq9CdsM
April 12th 2021, 1:04pm
kevinjaybe @kevinjaybe
RT @fda_tracker: $SGEN New PDUFA Date 2021-10-10 SEAGEN INC. Link:https://t.co/LwFaMxaEoi Calendar:https://t.co/sCt1qKoMdr
April 12th 2021, 1:04pm
fda_tracker @fda_tracker
$SGEN New PDUFA Date 2021-10-10 SEAGEN INC. Link:https://t.co/LwFaMxaEoi Calendar:https://t.co/sCt1qKoMdr
April 12th 2021, 1:04pm
newsfilterio @newsfilterio
Seagen: The New Oncology Hope $SGEN https://t.co/nL93aGLzXD
April 12th 2021, 8:04am
StckPro @StckPro
$SGEN NEW ARTICLE : Seagen: The New Oncology Hope https://t.co/iq1UcvU0TF Get all the latest $SGEN related news her… https://t.co/DIY3BXt55v
April 12th 2021, 8:04am
SeekingAlpha @SeekingAlpha
$SGEN - Seagen: The New Oncology Hope. https://t.co/lTzQtmBblJ #economy #investing #stocks
April 12th 2021, 8:04am
MrBigAustinTx @MrBigAustinTx
@GermanBiotech @rymankoly No doubt that 060 has a great chance of delivering great results, but also $SGEN and… https://t.co/YTFVLNPNmg
April 12th 2021, 3:04am
Gambiste1 @Gambiste1
RT @GermanBiotech: @GreenPollex Partnership seems overstated in this context, as far as I can recall $SGEN will only supply tucatinib (unde…
April 12th 2021, 12:04am
GermanBiotech @GermanBiotech
@GreenPollex Partnership seems overstated in this context, as far as I can recall $SGEN will only supply tucatinib… https://t.co/yY0LXEW3AU
April 12th 2021, 12:04am
1stOncology @1stOncology
#Seagen to Highlight Data from Novel #TargetedTherapies at #AACR21 $SGEN https://t.co/k8lGYhXAhO
April 11th 2021, 5:04am
insidersanalyt1 @insidersanalyt1
on 2021-04-09 $SGEN insiders' SOLD 300 securities equal to 0.0002% of outstanding shares. #finance #trading… https://t.co/m0s4tUhMxe
April 10th 2021, 8:04pm
formwhisperscom @formwhisperscom
#FWSells $SGEN SIEGALL CLAY B, President and CEO of Seagen Inc. sold 29,353 shares on 2021-04-09. https://t.co/kIhi9GXVrz
April 10th 2021, 3:04am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in SEATTLE GENETICS $SGEN https://t.co/5sAPCcECix
April 10th 2021, 2:04am
insiderbuyings @insiderbuyings
$SGEN new insider selling: 29353 shares. https://t.co/7ZgigPuM5l
April 10th 2021, 12:04am
StockTexts @StockTexts
$SGEN Seattle Genetics, Inc. SEC Filing: Form 4 https://t.co/4Wbs042Lzf
April 10th 2021, 12:04am
InsiderAlerts4U @InsiderAlerts4U
$SGEN: New Insider Filing on Seagen Inc.'s President and CEO CLAY B SIEGALL: https://t.co/aLJhiDY6Ej
April 10th 2021, 12:04am
StockTexts @StockTexts
$SGEN Seattle Genetics, Inc. SEC Filing: Form 4 https://t.co/4Wbs03LaHH
April 10th 2021, 12:04am
fintel_io @fintel_io
Insider Clay B Siegall reports selling 29,353 shares of $SGEN for a total cost of $4,220,739.96 https://t.co/NrboZ9AP0x
April 10th 2021, 12:04am
MaisaCorp @MaisaCorp
$SGEN announced that preclinical data from its pipeline of novel targeted oncology drugs will be presented at the A… https://t.co/SYBzZQpZ5U
April 9th 2021, 10:04pm
AlertTrade @AlertTrade
RT @Briefingcom: $SGEN: Seagen and Genmab (GMAB) announce FDA acceptance for Priority Review of BLA for tisotumab vedotin https://t.co/ZnHg…
April 9th 2021, 10:04pm
Briefingcom @Briefingcom
$SGEN: Seagen and Genmab (GMAB) announce FDA acceptance for Priority Review of BLA for tisotumab vedotin https://t.co/ZnHgdIDLKx
April 9th 2021, 10:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.